Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04274153 · ClinicalTrials.gov registry record · Phase 4
HPV Vaccination Study in Postpartum Women
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 225
- Enrollment target
NCT04274153: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT04274153 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 225 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04274153, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 225 participants
- Enrollment target
Study Summary
The human papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the United States (U.S.) and is responsible for a wide range of conditions, including cancers within the anogenital tract and the oropharynx. In just the U.S. alone, it's estimated that HPV causes 330,000 cases of precancerous cervical dysplasia and 12,000 cases of cervical cancer. The investigators propose a 2-dose HPV vaccination study in women seeking postpartum care at Johns Hopkins University. The investigators will measure the immunogenicity and acceptability of the vaccine in the postpartum setting.
Interventions
- BIOLOGICAL Gardasil9
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2023-02-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04274153
The ClinicalTrials.gov registry entry for NCT04274153 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gardasil9 is the first listed.
NCT04274153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04274153 about?
NCT04274153 is a clinical study titled "HPV Vaccination Study in Postpartum Women". The human papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the United States (U.S.) and is responsible for a wide range of conditions, including cancers within the anogenital tract and the oropharynx. In just the U.S. alone, it's estimated that HPV causes 330,000 cases...
What is the current status of trial NCT04274153?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 225 participants. The study started on 2020-08-03. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT04274153?
The interventions under investigation include: Gardasil9 (BIOLOGICAL).
Who is sponsoring clinical trial NCT04274153?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.